Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
25
NCT05901480
An Investigator Initiated Study for OTOV101N+OTOV101C Injection
Phase: N/A
Role: Lead Sponsor
Start: Jun 26, 2023
Completion: Feb 18, 2025